Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 2731 AL 2745

Acute Cervical Dystonia Induced by Clebopride

Choi JK, Hong JY.

Case Rep Neurol Med. 2017;2017:2834349. doi: 10.1155/2017/2834349. Epub 2017 Nov 28.

Disorders of metal metabolism

Ferreira CR, Gahl WA.

Transl Sci Rare Dis. 2017 Dec 18;2(3-4):101-139. doi: 10.3233/TRD-170015.

[The efficacy of botulinotherapy in the correction of the pain syndrome and quality of life of patients with cervical dystonia]

Karakulova YV, Loginova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(12):33-36. doi: 10.17116/jnevro201711712133-36.

Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients

Delli Pizzi S, Bellomo RG, Carmignano SM, Ancona E, Franciotti R, Supplizi M, Barassi G, Onofrj M, Bonanni L, Saggini R.

Medicine (Baltimore). 2017 Dec;96(50):e8732. doi: 10.1097/MD.0000000000008732.

Dystonic Seizures and Intense Hyperperfusion of the Basal Ganglia in a Patient with Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Matsumoto H, Hashida H, Takahashi Y.

Case Rep Neurol. 2017 Nov 23;9(3):272-276. doi: 10.1159/000484200. eCollection 2017 Sep-Dec.

Generalized dystonia : unusual mode of revelation of Moyamoya disease

Laatar F, Kacem I, Nasri A, Ben Djebara M, Gargouri A, Gouider R.

Tunis Med. 2017 Dec;95(12):504-505.

ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders

Chong CM, Ai N, Lee SM.

Curr Drug Targets. 2017;18(4):455-462. doi: 10.2174/1389450117666160401123825.

Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?

Carvalho AN, Firuzi O, Gama MJ, Horssen JV, Saso L.

Curr Drug Targets. 2017 Mar 30;18(6):705-718. doi: 10.2174/1389450117666160401120514.

Epigenetic Basis of Neuronal and Synaptic Plasticity

Karpova NN, Sales AJ, Joca SR.

Curr Top Med Chem. 2017;17(7):771-793. doi: 10.2174/1568026616666160414124628.

MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?

Nadim WD, Simion V, Benedetti H, Pichon C, Baril P, Morisset-Lopez S.

Curr Neuropharmacol. 2017;15(2):260-275. doi: 10.2174/1570159x14666160709001441.

Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities

Simion V, Nadim WD, Benedetti H, Pichon C, Morisset-Lopez S, Baril P.

Curr Neuropharmacol. 2017;15(2):276-290. doi: 10.2174/1570159x14666160630210422.

Purinergic Signalling and Neurological Diseases: An Update

Burnstock G.

CNS Neurol Disord Drug Targets. 2017;16(3):257-265. doi: 10.2174/1871527315666160922104848.

Recombinant Antibody Fragments for Neurodegenerative Diseases

Manoutcharian K, Perez-Garmendia R, Gevorkian G.

Curr Neuropharmacol. 2017;15(5):779-788. doi: 10.2174/1570159X01666160930121647.

Molecular Imaging of Huntington's Disease

Ciarmiello A, Giovacchini G, Giovannini E, Lazzeri P, Borsò E, Mannironi A, Mansi L.

J Cell Physiol. 2017 Aug;232(8):1988-1993. doi: 10.1002/jcp.25666. Epub 2017 Mar 24.

The role of endoplasmic reticulum stress in neurodegenerative disease

Xiang C, Wang Y, Zhang H, Han F.

Apoptosis. 2017 Jan;22(1):1-26. doi: 10.1007/s10495-016-1296-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias